These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32670540)

  • 1. Do neuroendocrine carcinomas and mixed neuroendocrine-non-neuroendocrine neoplasm of the gastrointestinal tract have the same prognosis? A
    Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Pang S; Zhang Q; Lin R
    Ther Adv Endocrinol Metab; 2020; 11():2042018820938304. PubMed ID: 32670540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of mixed neuroendocrine non-neuroendocrine neoplasms (MiNENs): A SEER database analysis of 767 cases.
    Song H; Yang S; Zhang Y; Hua Y; Kleeff J; Liu Q; Liao Q
    Front Oncol; 2022; 12():1007317. PubMed ID: 36698410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
    Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
    Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study.
    Zheng M; Li T; Li Y; Zhang T; Zhang L; Ma W; Zhou L
    Front Oncol; 2020; 10():1660. PubMed ID: 32903647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.
    Huang YC; Yang NN; Chen HC; Huang YL; Yan WT; Yang RX; Li N; Zhang S; Yang PP; Feng ZZ
    World J Gastroenterol; 2021 Feb; 27(7):624-640. PubMed ID: 33642833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
    Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
    Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in clinicopathology and prognosis between gastroesophageal junctional and gastric non-cardiac neuroendocrine carcinomas: a retrospective comparison study of consecutive 56 cases from a single institution in China.
    Cheng Y; Zhang X; Zhou X; Xu K; Lin M; Huang Q
    Am J Cancer Res; 2022; 12(10):4737-4750. PubMed ID: 36381336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discussion on the benefits of different treatment strategies in elderly and non-elderly patients with appendix MiNEN: a retrospective study based on SEER database.
    Xing X; Zhang Y; Wang L; Wang Y; Zhang Z; Li Z; Li M
    Int J Colorectal Dis; 2023 Apr; 38(1):93. PubMed ID: 37039889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).
    Jacob A; Raj R; Allison DB; Soares HP; Chauhan A
    Curr Treat Options Oncol; 2022 May; 23(5):721-735. PubMed ID: 35347561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
    Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
    World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of gastric neuroendocrine neoplasms: A comprehensive analysis.
    Zi M; Ma Y; Chen J; Pang C; Li X; Yuan L; Liu Z; Yu P
    Cancer Med; 2024 Feb; 13(4):e7011. PubMed ID: 38457192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of pancreatic neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm.
    Kinowaki Y; Fukumura Y; Kawade G; Sugita K; Kinowaki K; Akahoshi K; Kobayashi M; Ono H; Kudo A; Tanabe M; Akashi T; Ohashi K; Kurata M
    Gene; 2024 Jan; 893():147916. PubMed ID: 37866661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
    Ho YH; Hsu CY; Yau Li AF; Liang WY
    Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NET G3 vs NEC: p53 and Rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?
    Dinu A; Aschie M; Cozaru GC; Mitroi AF; Grasa CN; Iordache IE; Deacu M; Orasanu CI; Nicolau AA; Baltatescu GI
    J Gastrointestin Liver Dis; 2023 Jun; 32(2):162-169. PubMed ID: 37345605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features and lymph node metastasis pattern of the cervical MiNEN.
    Xu H; Zhao Z; Zhu Y
    Endocrine; 2022 May; 76(2):474-483. PubMed ID: 35102503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    Chen Y; Tu J; Zhou S; Fu J; Wang Q
    Int J Colorectal Dis; 2021 Apr; 36(4):745-756. PubMed ID: 33415449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm.
    Maragliano R; Libera L; Carnevali I; Pensotti V; De Vecchi G; Testa M; Amaglio C; Leoni E; Formenti G; Sessa F; Furlan D; Uccella S
    Endocr Pathol; 2022 Sep; 33(3):400-410. PubMed ID: 34342838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).
    Lou L; Lv F; Wu X; Li Y; Zhang X
    Eur J Surg Oncol; 2021 Feb; 47(2):323-330. PubMed ID: 32907775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed neuroendocrine non-neuroendocrine neoplasm of the gallbladder complicated by a pancreaticobiliary maljunction of a non-dilated biliary duct: A case report.
    Wagatsuma K; Akita K; Motoya M; Kimura Y; Sugita S; Hirano T; Kawakami Y; Numata Y; Ishigami K; Masaki Y; Murota A; Shitani M; Akutsu N; Sasaki S; Nakase H
    Medicine (Baltimore); 2021 Oct; 100(39):e27336. PubMed ID: 34596138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.